Compound Evidence File
#EC-2026-0481
Cerebrolysin
Filed under Peptides. The bureau holds 222 laboratory returns for this compound from 102 distinct subjects. Scores below are per-subject aggregates; open a subject row for the underlying evidence.
Cross-Index
Subjects Shipping This Compound
102 SUBJECTS| Subject | Grade | Samples | Mean | Min | Max | First seen | Last seen |
|---|---|---|---|---|---|---|---|
| WuXi TIDESCASE #VI-2026-0335 | A | 5 | 10.0 | 9.9 | 10.0 | 23 Apr 2026 | 18 Jul 2026 |
| Sangon BioCASE #VI-2026-0671 | A | 4 | 10.0 | 10.0 | 10.0 | 14 May 2026 | 1 Jul 2026 |
| QYAOBIOCASE #VI-2026-0861 | A | 4 | 10.0 | 9.9 | 10.0 | 24 Jan 2026 | 4 Jul 2026 |
| Kerui PeptidesCASE #VI-2026-0626 | A | 4 | 10.0 | 10.0 | 10.0 | 27 Feb 2026 | 26 Jun 2026 |
| Hubei JianxiangCASE #VI-2026-0048 | A | 4 | 10.0 | 10.0 | 10.0 | 15 Jan 2026 | 11 Apr 2026 |
| Shanghai Sigma AudleyCASE #VI-2026-0505 | A | 4 | 10.0 | 9.9 | 10.0 | 11 Mar 2026 | 13 Jun 2026 |
| AsymchemCASE #VI-2026-0091 | A | 4 | 10.0 | 9.9 | 10.0 | 22 Apr 2026 | 20 Jul 2026 |
| JEEP PeptidesCASE #VI-2026-0457 | A | 3 | 10.0 | 10.0 | 10.0 | 25 Feb 2026 | 8 Jul 2026 |
| Chinese Peptide CompanyCASE #VI-2026-0184 | A | 3 | 10.0 | 9.9 | 10.0 | 3 Dec 2025 | 16 Jul 2026 |
| Hybio PharmaceuticalCASE #VI-2026-0065 | A | 3 | 10.0 | 9.9 | 10.0 | 12 Jun 2026 | 15 Jul 2026 |
| GenScript PeptidesCASE #VI-2026-0860 | A | 3 | 10.0 | 10.0 | 10.0 | 26 Apr 2026 | 3 Jul 2026 |
| Sigma-AldrichCASE #VI-2026-0829 | A | 3 | 10.0 | 9.9 | 10.0 | 4 Jan 2026 | 6 Aug 2026 |
| Thermo Fisher ScientificCASE #VI-2026-0142 | A | 3 | 10.0 | 9.9 | 10.0 | 18 Apr 2026 | 9 Jul 2026 |
| PolyPeptide GroupCASE #VI-2026-0143 | A | 2 | 10.0 | 10.0 | 10.0 | 17 Mar 2026 | 22 Apr 2026 |
| NUPEPS PeptidesCASE #VI-2026-0896 | X | 1 | 10.0 | 10.0 | 10.0 | 27 Feb 2025 | 27 Feb 2025 |
| Oasis PeptidesCASE #VI-2026-0404 | X | 1 | 10.0 | 10.0 | 10.0 | 3 Jul 2025 | 3 Jul 2025 |
| Tianjin Finder Chemical TFCCASE #VI-2026-0693 | A | 5 | 9.9 | 9.9 | 10.0 | 14 Nov 2025 | 16 Apr 2026 |
| HomopeptideCASE #VI-2026-0760 | A | 4 | 9.9 | 9.9 | 10.0 | 24 May 2026 | 24 May 2026 |
| Shanghai ERP BiotechnologyCASE #VI-2026-0936 | A | 4 | 9.9 | 9.9 | 10.0 | 1 Nov 2025 | 5 Apr 2026 |
| Flourishglobal PeptideCASE #VI-2026-0630 | A | 4 | 9.9 | 9.9 | 10.0 | 25 Dec 2025 | 16 Jul 2026 |
| AmbioPharmCASE #VI-2026-0177 | A | 4 | 9.9 | 9.9 | 10.0 | 14 Feb 2026 | 1 Aug 2026 |
| Mokemei BiotechnologyCASE #VI-2026-0540 | A | 3 | 9.9 | 9.9 | 10.0 | 13 Dec 2025 | 16 Jun 2026 |
| BachemCASE #VI-2026-0314 | A | 2 | 9.9 | 9.9 | 10.0 | 5 Nov 2025 | 9 Nov 2025 |
| Shanghai Wibson BiotechnologyCASE #VI-2026-0379 | A | 2 | 9.9 | 9.9 | 10.0 | 12 Mar 2026 | 5 May 2026 |
| SinoPepCASE #VI-2026-0387 | A | 2 | 9.9 | 9.9 | 10.0 | 23 Apr 2026 | 13 Jul 2026 |
| Orbitrex PeptidesCASE #VI-2026-0812 | X | 1 | 9.9 | 9.9 | 9.9 | 13 Feb 2025 | 13 Feb 2025 |
| Risynth BioCASE #VI-2026-0672 | X | 1 | 9.8 | 9.8 | 9.8 | 27 Feb 2025 | 27 Feb 2025 |
| Nantong Guangyuan Chemical GYCCASE #VI-2026-0284 | A | 2 | 9.4 | 9.3 | 9.4 | 24 May 2026 | 24 May 2026 |
| Shanghai Sigma Audley SSACASE #VI-2026-0486 | A | 3 | 9.3 | 8.3 | 9.9 | 24 May 2026 | 24 May 2026 |
| Glbiochem (Shanghai)CASE #VI-2026-0704 | A | 8 | 8.8 | 7.6 | 10.0 | 25 May 2026 | 25 May 2026 |
| PeptiAtlasCASE #VI-2026-0739 | X | 1 | 8.7 | 8.7 | 8.7 | 16 Mar 2025 | 16 Mar 2025 |
| Atomik LabzCASE #VI-2026-0327 | X | 1 | 8.6 | 8.6 | 8.6 | 13 Jun 2025 | 13 Jun 2025 |
| Laicuinuo LCNCASE #VI-2026-0223 | X | 1 | 8.5 | 8.5 | 8.5 | 28 Mar 2025 | 28 Mar 2025 |
| Wuhan Wansheng Bio (WWB)CASE #VI-2026-0594 | A | 6 | 8.4 | 7.2 | 9.6 | 21 May 2026 | 21 May 2026 |
| Qingdao Sigma Chemical QSCCASE #VI-2026-0538 | A | 6 | 8.4 | 7.2 | 9.1 | 24 May 2026 | 24 May 2026 |
| Lux Synth AminosCASE #VI-2026-0700 | X | 1 | 8.4 | 8.4 | 8.4 | 2 Jul 2025 | 2 Jul 2025 |
| Verified PeptidesCASE #VI-2026-0407 | X | 3 | 8.3 | 7.3 | 10.0 | 20 Jun 2025 | 24 May 2026 |
| AKS ChemCASE #VI-2026-0313 | X | 1 | 8.3 | 8.3 | 8.3 | 28 Mar 2025 | 28 Mar 2025 |
| Yiwu Aozuo Trading CoCASE #VI-2026-0798 | X | 2 | 8.2 | 7.4 | 8.9 | 2 Apr 2025 | 19 Jan 2026 |
| Peptide WorldwideCASE #VI-2026-0217 | X | 1 | 8.2 | 8.2 | 8.2 | 2 Jul 2025 | 2 Jul 2025 |
| Zenith Jove Peptide ZJCASE #VI-2026-0570 | X | 2 | 8.1 | 7.0 | 9.1 | 27 Feb 2025 | 21 May 2026 |
| Xingtai Pukelai Technology CoCASE #VI-2026-0850 | X | 1 | 8.1 | 8.1 | 8.1 | 13 Jun 2025 | 13 Jun 2025 |
| Top PeptideCASE #VI-2026-0721 | X | 2 | 8.0 | 7.8 | 8.2 | 7 May 2025 | 26 Jan 2026 |
| Precision Peptide CoCASE #VI-2026-0559 | X | 2 | 8.0 | 7.4 | 8.6 | 3 Jun 2025 | 23 May 2026 |
| Xian Yihang TechnologyCASE #VI-2026-0656 | X | 2 | 7.9 | 5.9 | 9.9 | 6 May 2025 | 19 Jan 2026 |
| Pura PeptidesCASE #VI-2026-0307 | X | 1 | 7.9 | 7.9 | 7.9 | 25 Apr 2025 | 25 Apr 2025 |
| TCICASE #VI-2026-0650 | X | 1 | 7.9 | 7.9 | 7.9 | 6 May 2025 | 6 May 2025 |
| Peptide PartnersCASE #VI-2026-0295 | X | 4 | 7.8 | 6.8 | 10.0 | 6 May 2025 | 17 May 2026 |
| Peptronix Bio PTBCASE #VI-2026-0979 | X | 1 | 7.6 | 7.6 | 7.6 | 21 May 2025 | 21 May 2025 |
| Bulk Peptide WholesaleCASE #VI-2026-0319 | A | 2 | 7.4 | 7.3 | 7.6 | 7 May 2025 | 21 May 2026 |
| Pure RawzCASE #VI-2026-0767 | X | 1 | 7.4 | 7.4 | 7.4 | 9 Jun 2025 | 9 Jun 2025 |
| Yabang PeptideCASE #VI-2026-0148 | X | 1 | 7.2 | 7.2 | 7.2 | 20 Jun 2025 | 20 Jun 2025 |
| Zhejiang Yichenkang BiotechnologyCASE #VI-2026-0269 | X | 1 | 7.2 | 7.2 | 7.2 | 24 Apr 2025 | 24 Apr 2025 |
| Qing Li PeptideCASE #VI-2026-0469 | X | 8 | 7.0 | 4.3 | 8.9 | 17 Dec 2024 | 26 Jan 2026 |
| Shanghai OuDaXin New Material Technology CenterCASE #VI-2026-0498 | X | 1 | 7.0 | 7.0 | 7.0 | 8 Jul 2025 | 8 Jul 2025 |
| Peptide TechnologiesCASE #VI-2026-0694 | X | 1 | 7.0 | 7.0 | 7.0 | 2 Jul 2025 | 2 Jul 2025 |
| Prime PeptidesCASE #VI-2026-0696 | X | 1 | 6.9 | 6.9 | 6.9 | 2 Jul 2025 | 2 Jul 2025 |
| Bio PepzCASE #VI-2026-0436 | X | 1 | 6.9 | 6.9 | 6.9 | 6 May 2025 | 6 May 2025 |
| Rayshine Peptide BiochemicalsCASE #VI-2026-0545 | X | 1 | 6.9 | 6.9 | 6.9 | 11 Jun 2025 | 11 Jun 2025 |
| Skye PeptidesCASE #VI-2026-0451 | X | 7 | 6.7 | 5.0 | 9.2 | 13 Jun 2025 | 23 May 2026 |
| Mix PeptidesCASE #VI-2026-0699 | X | 1 | 6.7 | 6.7 | 6.7 | 11 Jun 2025 | 11 Jun 2025 |
| Shanxi Qianyecao Biotech QYCCASE #VI-2026-0189 | X | 5 | 6.6 | 5.4 | 7.3 | 20 Jun 2025 | 20 May 2026 |
| UWA Elite PeptidesCASE #VI-2026-0130 | X | 1 | 6.6 | 6.6 | 6.6 | 2 Apr 2025 | 2 Apr 2025 |
| Hunan GoodPeptides Biotech CoCASE #VI-2026-0370 | X | 1 | 6.6 | 6.6 | 6.6 | 7 May 2025 | 7 May 2025 |
| Accelerate LabsCASE #VI-2026-0686 | X | 1 | 6.6 | 6.6 | 6.6 | 27 Feb 2025 | 27 Feb 2025 |
| Shandong Shengyuan Peptide TechnologyCASE #VI-2026-0634 | X | 1 | 6.5 | 6.5 | 6.5 | 25 Apr 2025 | 25 Apr 2025 |
| Zztai PeptideCASE #VI-2026-0192 | C | 2 | 6.4 | 6.3 | 6.5 | 8 Jul 2025 | 26 Jan 2026 |
| Pure Tested PeptidesCASE #VI-2026-0225 | X | 1 | 6.4 | 6.4 | 6.4 | 17 Dec 2024 | 17 Dec 2024 |
| Peptide CraftersCASE #VI-2026-0994 | X | 1 | 6.2 | 6.2 | 6.2 | 3 Jul 2025 | 3 Jul 2025 |
| Shanghai BaojuCASE #VI-2026-0233 | X | 2 | 6.1 | 5.4 | 6.8 | 24 Apr 2025 | 23 May 2026 |
| Amino LairCASE #VI-2026-0413 | X | 1 | 6.1 | 6.1 | 6.1 | 2 Jul 2025 | 2 Jul 2025 |
| Paramount PeptidesCASE #VI-2026-0550 | X | 6 | 6.0 | 5.4 | 7.7 | 3 Jun 2025 | 24 May 2026 |
| SRY LabsCASE #VI-2026-0657 | X | 3 | 5.9 | 4.6 | 8.3 | 7 May 2025 | 20 May 2026 |
| OmegAminoCASE #VI-2026-0014 | X | 1 | 5.8 | 5.8 | 5.8 | 6 May 2025 | 6 May 2025 |
| Shaanxi Dideu MedichemCASE #VI-2026-0499 | X | 1 | 5.8 | 5.8 | 5.8 | 25 Apr 2025 | 25 Apr 2025 |
| Wolverine PeptidesCASE #VI-2026-0262 | X | 1 | 5.8 | 5.8 | 5.8 | 3 Jul 2025 | 3 Jul 2025 |
| YimeiCASE #VI-2026-0081 | X | 3 | 5.6 | 5.3 | 6.2 | 3 Jul 2025 | 24 May 2026 |
| Xingtai Lesda TechnologyCASE #VI-2026-0381 | X | 1 | 5.5 | 5.5 | 5.5 | 28 Mar 2025 | 28 Mar 2025 |
| Swiss ChemsCASE #VI-2026-0030 | X | 1 | 5.5 | 5.5 | 5.5 | 16 Mar 2025 | 16 Mar 2025 |
| Dragon PharmaCASE #VI-2026-0519 | X | 1 | 5.5 | 5.5 | 5.5 | 16 Mar 2025 | 16 Mar 2025 |
| Eros PeptidesCASE #VI-2026-0918 | X | 1 | 5.4 | 5.4 | 5.4 | 21 May 2025 | 21 May 2025 |
| Planet PeptideCASE #VI-2026-0092 | X | 2 | 5.2 | 4.9 | 5.4 | 21 May 2025 | 25 May 2026 |
| Yongkang Nuoao Trading CoCASE #VI-2026-0646 | X | 1 | 5.2 | 5.2 | 5.2 | 9 Jun 2025 | 9 Jun 2025 |
| Coastal PeptidesCASE #VI-2026-0958 | X | 2 | 5.0 | 4.9 | 5.0 | 7 May 2025 | 17 May 2026 |
| WllyBIOCASE #VI-2026-0470 | X | 1 | 4.9 | 4.9 | 4.9 | 3 Jul 2025 | 3 Jul 2025 |
| ZZQ PeptidesCASE #VI-2026-0550 | E | 2 | 4.7 | 4.6 | 4.7 | 24 Apr 2025 | 20 May 2026 |
| Alpha-GenCASE #VI-2026-0905 | X | 2 | 4.7 | 3.6 | 5.8 | 25 Apr 2025 | 21 May 2026 |
| Zhang TYCASE #VI-2026-0070 | X | 1 | 4.6 | 4.6 | 4.6 | 3 Jun 2025 | 3 Jun 2025 |
| Limitless Life NootropicsCASE #VI-2026-0980 | X | 1 | 4.6 | 4.6 | 4.6 | 21 May 2025 | 21 May 2025 |
| ZhuoYan labCASE #VI-2026-0902 | X | 2 | 4.4 | 4.4 | 4.4 | 2 Jul 2025 | 26 Jan 2026 |
| HybiopeptidesCASE #VI-2026-0305 | X | 1 | 4.3 | 4.3 | 4.3 | 25 Apr 2025 | 25 Apr 2025 |
| Shenzhen Loga Tech LG LOGACASE #VI-2026-0920 | X | 1 | 4.1 | 4.1 | 4.1 | 13 Feb 2025 | 13 Feb 2025 |
| Qingdao VitaConin International TradingCASE #VI-2026-0504 | X | 1 | 3.6 | 3.6 | 3.6 | 3 Jun 2025 | 3 Jun 2025 |
| LOOKBiotechCASE #VI-2026-0807 | X | 1 | 2.7 | 2.7 | 2.7 | 11 Jun 2025 | 11 Jun 2025 |
| Marvel PeptideCASE #VI-2026-0507 | X | 1 | 2.1 | 2.1 | 2.1 | 9 Jun 2025 | 9 Jun 2025 |
| Shenzhen Jiechuang TradingCASE #VI-2026-0292 | X | 1 | 1.9 | 1.9 | 1.9 | 2 Apr 2025 | 2 Apr 2025 |
| Lejian Biotech PeptideCASE #VI-2026-0746 | X | 1 | 0.4 | 0.4 | 0.4 | 13 Feb 2025 | 13 Feb 2025 |
| Advanced Technology and IndustrialCASE #VI-2026-0133 | X | 1 | 0.1 | 0.1 | 0.1 | 14 Jan 2025 | 14 Jan 2025 |
| PepKitsCASE #VI-2026-0320 | X | 1 | 0.0 | 0.0 | 0.0 | 13 Feb 2025 | 13 Feb 2025 |
| NuLife PeptidesCASE #VI-2026-0980 | X | 1 | 0.0 | 0.0 | 0.0 | 2 Jul 2025 | 2 Jul 2025 |
| Explicit SarmsCASE #VI-2026-0017 | X | 1 | 0.0 | 0.0 | 0.0 | 3 Jul 2025 | 3 Jul 2025 |
| Hebei Chengtong TechnologyCASE #VI-2026-0520 | X | 1 | 0.0 | 0.0 | 0.0 | 27 Feb 2025 | 27 Feb 2025 |
Open any subject to view the batch-level evidence for Cerebrolysin alone.